1 Undervalued Growth Stock to Buy Now

In this video, I will talk about Novo Nordisk stock recent updates as well as VKTX.

👉A portion of this video is sponsored by The Motley Fool.

WATCH NEXT:

Don't forget to do your own research before buying into a stock!

DISCLAIMER: I do not provide personal investment advice and I am not a qualified licensed investment advisor. All information found here, including any ideas, opinions, views, predictions, forecasts, commentaries, suggestions, or stock picks, expressed or implied herein, are for informational, entertainment, or educational purposes only and should not be construed as personal investment advice. While the information provided is believed to be accurate, it may include errors or inaccuracies. I will not and cannot be held liable for any actions you take as a result of anything you read and/or view here. #investing #novonordisk

[JohnAyala-su]

I Hit $ 250, 590 today. Thank you for all the knowledge and nuggets you had thrown my way over the last week i started with 15k in last week 2025.... now i just hit $250, 590
...

[digitpersona]

Yes I'd like the video on the European defense stocks

[brians]

Thanks for doing the video I suggested!

[dontplayformenero]

Good shout.

Indra Sistemas... Pay attention to this folks. European defense company under the radar and still undervalued

[noyavargel]

Great video great company too many stock to buy now with all marmet on discount

[bjornostlund]

I have been investing in European stocks at the same time buying US shares. One great opportunity in Europe )´(UK) is Big Yellow Group (BYG), It is a REIT type of stock. They are focusing on Self Storage. Since Europe is far behind US when it comes to Self Storage REITs, the potential is fantastic. Buy and Hold !

[GeorgeO-]

Thanks. Interesting price level. Good chance to buy some in the Deutsche exchange to get some additional euro exposure.

[danieldavenport]

Video on EU defence would be great please 😊

[DonCarso]

Omg there's too much to buy. Id love to see another drop like 2020 but we're not there. I'm loading up on what we have available now. Novo sounds good but I think there are better. The future will let me know how things went.

[hansschmidt]

A video on defense stocks would be great, especially a comparison of their valuation.

[odoacredacalcutta]

One of the few big farma that's been growing revenue significantly and steadily over the years. I've been accumulating for a while. Part of their capex is also spent on NVDA's gpus to run molecular simulations to discover new drugs. Best eu company together with ASML imo.

[sirobin]

Good video. I have my eye on Novo for a month or so, I was not paying attention to GLP-1 until recently, now that I am aware of it I think whichever company gets a "weight loss" pill that works and is FDA approved, will rule this market for a long time, this is a branding opportunity, sort of like when someone tells you to "Google" something, people will tell you to take a "Novo" to lose those 15 pounds. Even if the first pill is not as effective as Wall street wants, its doesn't matter, its all about perception.

[franciscodasse]

For me the company has good accounting and fundamentals.

[otbovertheboard]

Any concerns about a few of their patents expiring in March 2026?

[jnmc]

Novo Nordisk is a no brainer… the only, or main, concerns are Trumps tariff threats. He even mentioned Denmark specifically due to the Greenland issue.

[moosp]

Wallstreet misunderstood Redefine 2. It's for people with diabetes 2 that have a hard time losing weight and the results are on par with LLY. People expected 25%, but that's completely misunderstood. 25% target will be for Redefine 4.

[AbdulRehman-hvor]

Just a question are u aware or holding ANET & celestica? Or u views on it?

[brsaweda]

Love your analysis! Could I interest you to have a look at this medium-size German / Austrian tech company KONTRON. The price keeps going up.

[CostaBatis]

Haven’t seen the video yet, but I am sure that… “So, there is that”! 😂

[sebastianballack]

the problem is eli lilly has better patient outcomes